CIK 0001819576 · Non-accelerated filer
Liquidia Corp
Sign in to watch- Ticker
- LQDA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 851710962
- Phone
- 919.328.4400
- Business address
- 419 DAVIS DRIVE, SUITE 100, MORRISVILLE, NC, 27560
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $23,494,367
- in 17 filings, $12.2M under 10b5-1 plans
Net −$23,494,367. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-04-10 | Adair Jason Chief Business Officer | Option exercise 10b5-1 | +2,474 | 218,859 | ||
| 2026-04-10 | Adair Jason Chief Business Officer | Option exercise 10b5-1 | +3,868 | 222,727 | ||
| 2026-04-10 | Adair Jason Chief Business Officer | Option exercise · Restricted Stock Units 10b5-1 | −3,906 | 11,719 | ||
| 2026-04-10 | Adair Jason Chief Business Officer | Option exercise · Performance Stock Units 10b5-1 | −2,474 | 17,320 | ||
| 2026-04-10 | Adair Jason Chief Business Officer | Option exercise · Performance Stock Units 10b5-1 | −3,868 | 42,553 | ||
| 2026-04-10 | Boyle Dana Chief Accounting Officer | Option exercise 10b5-1 | +3,179 | 182,019 | ||
| 2026-04-10 | Boyle Dana Chief Accounting Officer | Option exercise · Performance Stock Units 10b5-1 | −3,179 | 34,966 | ||
| 2026-04-10 | Kaseta Michael CFO and COO | Option exercise 10b5-1 | +23,821 | $2.79 | $66K | 435,676 |
| 2026-04-10 | Kaseta Michael CFO and COO | Sale 10b5-1 | −23,821 | $40.14 | $956K | 411,855 |
| 2026-04-10 | Kaseta Michael CFO and COO | Option exercise 10b5-1 | +5,828 | 417,683 | ||
| 2026-04-10 | Kaseta Michael CFO and COO | Option exercise 10b5-1 | +7,050 | 424,733 | ||
| 2026-04-10 | Kaseta Michael CFO and COO | Option exercise · Incentive Stock Option (right to buy) 10b5-1 | −23,821 | 100,505 | ||
| 2026-04-10 | Kaseta Michael CFO and COO | Option exercise · Performance Stock Units 10b5-1 | −5,828 | 40,797 | ||
| 2026-04-10 | Kaseta Michael CFO and COO | Option exercise · Performance Stock Units 10b5-1 | −7,050 | 77,547 | ||
| 2026-04-10 | Krepp Sarah Chief Human Resource Officer | Option exercise | +3,179 | 151,576 | ||
| 2026-04-10 | Krepp Sarah Chief Human Resource Officer | Option exercise · Performance Stock Units | −3,179 | 34,966 | ||
| 2026-04-10 | Saggar Rajeev Chief Medical Officer | Option exercise 10b5-1 | +3,531 | 178,004 | ||
| 2026-04-10 | Saggar Rajeev Chief Medical Officer | Option exercise 10b5-1 | +4,486 | 182,490 | ||
| 2026-04-10 | Saggar Rajeev Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −3,531 | 24,715 | ||
| 2026-04-10 | Saggar Rajeev Chief Medical Officer | Option exercise · Performance Stock Units 10b5-1 | −4,486 | 49,349 |
Page 13 of 18 · 344 trades